Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Immunovia Q2 2021 Presentation

August 19, 2021

Immunovia Q2 Report 2021 presentation from August 19th, 2021 with CEO Patrik Dahlen; Medical Director Dr. Thomas King and Sr. Marketing Director US Cindy Callahan